
KGN Bio-Tech Limited
About KGN Bio-Tech Limited
Data last updated:
KGN Bio-Tech Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Kgn Enterprises Limited. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 06 April 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U01400MH2010PLC201743. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Janki Mrunal Vaishya and Ismail Memon.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.2 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹26,247 (net margin 8.2%) and EBITDA of ₹35,470 (EBITDA margin 11.1%). Revenue has grown at a compounded annual rate (CAGR) of 53% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
KGN Bio-Tech Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address23 Vaswani Mansion 4th Floor Dinshaw Vaccha Road Opp. K.C. College, Churchgate, Mumbai, Maharashtra, India – 400020
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of KGN Bio-Tech Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of KGN Bio-Tech Limited
FY 2025 filings availableKGN Bio-Tech Limited reported revenue of ₹3.2 Lakh (up 215% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 53% over five years, including 215% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35,470 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26,247 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.1% | ||||
| Net Profit Margin | 8.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of KGN Bio-Tech Limited, buy the company report.
Board of directors of KGN Bio-Tech Limited
KGN Bio-Tech has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Janki Mrunal Vaishya | Director | 13 Nov 2018 | 8 Years 0 Months | Current |
| Ismail Memon | Director | 10 Aug 2010 | 16 Years 3 Months | Current |
| Babulal Jethalal Hirani | Director | 06 Apr 2010 | 16 Years 7 Months | Current |
| Mohsin Ismail Memon | Additional Director | 15 Jan 2014 | 12 Years 10 Months | Current |
Auditor
KGN Bio-Tech Limited is audited by KIRIT & Co. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KIRIT & Co. | FY 2017 | 132282W |
Shareholding
The shareholding of KGN Bio-Tech Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of KGN Bio-Tech Limited, buy the company report.
Legal cases
No court or tribunal cases involving KGN Bio-Tech Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for KGN Bio-Tech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
KGN Bio-Tech has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of KGN Bio-Tech Limited, buy the company report.
Recent activity
KGN Bio-Tech Limited has 10 board changes on record since 2010: 7 appointments and 3 cessations. The latest: Janki Mrunal Vaishya was appointed as Director on 13 Nov 2018.
1 earlier event is in the company report.
Frequently asked questions
KGN Bio-Tech is an active public limited company based in Mumbai, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 06 April 2010 (16+ years old) and is registered under CIN U01400MH2010PLC201743.
KGN Bio-Tech has 4 current directors:
- Janki Mrunal Vaishya - Director
- Ismail Memon - Director
- Babulal Jethalal Hirani - Director
- Mohsin Ismail Memon - Additional Director
The latest financial statements of KGN Bio-Tech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. KGN Bio-Tech has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of KGN Bio-Tech is U01400MH2010PLC201743. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
KGN Bio-Tech was incorporated on 06 April 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Janki Mrunal Vaishya was appointed as Director on 13 Nov 2018. Aftabahmed Isamiya Kadri ceased to be Director on 15 Jan 2014. Mohsin Ismail Memon was appointed as Additional Director on 15 Jan 2014. KGN Bio-Tech has 10 board changes on record in total.
The registered office of KGN Bio-Tech is at 23 Vaswani Mansion 4th Floor Dinshaw Vaccha Road Opp. K.C. College, Churchgate, Mumbai, Maharashtra, India – 400020.
KGN Bio-Tech operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of KGN Bio-Tech is active non-compliant as of 29 September 2026. The company is actively filing with the Registrar of Companies.

